Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Nusantara Gemilang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 2.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Citra Nusantara Gemilang Tbk. is the larger of the two by market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (2.21M versus 33.1K). Which is the better fit depends on your goals.
| CGAS | OBAT | |
|---|---|---|
Market Cap | 272.81B | 167.37B |
Volume | 2.21M | 33.1K |
Lot | 22.09K | 331 |
Turnover | 337.61M | 8.17M |
Average Price | 152.83 | 246.91 |
Value | 337.61M | 8.17M |
Indicative Equilibrium Price | 154 | 246 |
Indicative Equilibrium Volume | 94.2K | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
